JBT MAREL Corp: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Aug 7, 2025 and accepted by EDGAR at Aug 6, 2025, 17:48 ET.
Management's discussion and analysis
As filed, 49,861 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q, our Annual Report on Form 10-K and other materials filed or to be filed by us with the Securities and Exchange Commission, as well as information in oral statements or other written statements made or to be made by us, contain statements that are, or may be considered to be, forward-looking statements. All statements that are not historical facts, including statements about our beliefs or expectations, are forward-looking statements. You can identify these forward-looking statements by the use of forward-looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” “foresees” or the negative version of those words or other comparable words and phrases. Any forward-looking statements contained in this Form 10-Q are based upon our historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. These forward-looking statements include, among others, statements relating to our business and our results of operations, the benefits or results of the Marel Transaction, our strategic plans, our restructuring plans and expected cost savings from those plans and our liquidity. The factors that could cause our actual results to differ materially from expectations include, but are not limited, to the following factors:
- the inability to successfully integrate the legacy businesses of JBT and Marel, operationally, technologically, culturally or otherwise, in a manner that permits the combined company to achieve the benefits and synergies anticipated from the Marel Transaction on the anticipated timeline or at all;
- fluctuations in our financial results;
- changes to tariffs, trade regulation, quotas, or duties;
- deterioration of economic conditions, including impacts from supply chain delays and reduced material or component availability;
- unanticipated delays or accelerations in our sales cycles;
- inflationary pressures, including increases in energy, raw material, freight and labor costs;
- disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business;
- fluctuations in currency exchange rates and interest rates;
- changes in food consumption patterns;
- impacts of pandemic illnesses, food borne illnesses and diseases to various agricultural products;
- weather conditions and natural disasters;
- the impact of climate change and environmental protection initiatives;
- acts of terrorism or war, including the ongoing conflicts in Ukraine and the Middle East;
- termination or loss of major customer contracts and risks associated with fixed-price contracts, particularly during periods of high inflation;
- customer sourcing initiatives;
- competition and innovation in our industries;
- our ability to develop and introduce new or enhanced products and services and keep pace with technological developments;
- difficulty in developing, preserving and protecting our intellectual property or defending claims of infringement;
- catastrophic loss at any of our facilities and business continuity of our information systems;
- cyber-security risks such as network intrusion or ransomware schemes;
- loss of key management and other personnel;
- potential liability arising out of the installation or use of our systems;
- our ability to comply with U.S. and international laws governing our operations and industries;
- increases in tax liabilities;
- work stoppages;
- our ability to remediate the material weaknesses relating to the Marel financial statements;
- availability of and access to financial and other resources; and
- the factors described under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent Annual Report on Form 10-K and in this and any future Quarterly Report on Form 10-Q.
If one or more of those or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Consequently, actual events and results may vary significantly from those included in or contemplated or implied by our forward-looking statements. The forward-looking statements included in this Form 10-Q are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or changes in circumstances or otherwise.
Executive Overview
JBT Marel Corporation is a leading global food and beverage technology solutions provider to high-value segments of the food and beverage industry. JBT Marel brings together the combined strengths of JBT and Marel with the goal of transforming the future of food.
We specialize in designing, manufacturing, and servicing cutting-edge technology, systems, and software for a broad range of food and beverage end markets. We aim to create better outcomes for our diverse customers by optimizing food yield and efficiency, improving food safety and quality, and enhancing uptime and proactive maintenance, all while reducing waste and resource use across the global food supply chain.
Our strategy capitalizes on favorable trends, as well as our leadership position, in the food and beverage processing industry. This strategy is based on a five-pronged approach to deliver continued growth and margin expansion.
- Strengthening Solutions and Value Proposition. We offer a broad portfolio of solutions developed for various food and beverage end markets to meet diverse customer and sustainability needs with precision and flexibility to fuel organic growth.
- Enhancing Service Offerings and Customer Relationships. Leveraging our industry expertise, we deliver high-quality service to minimize downtime, optimize performance, and strengthen customer partnerships with responsive support and reliable parts delivery.
- Advanced Digital and Software Capabilities. We deliver greater value through cutting-edge digital tools and software to improve productivity, reduce downtime, and optimize food and beverage processing.
- Focus on Innovation. By expanding our portfolio through cutting edge innovation we enhance technology leadership and deepen customer partnerships with advanced capabilities.
- Leveraging Our Scale to Expand Margins. By utilizing our resources and great talent, we drive efficiencies, achieve synergies, and deliver margin expansion, all while creating more value for our customers.
Our approach to Environmental, Social and Corporate Governance (ESG) builds on our culture and long tradition of concern for our employees’ health, safety, and well-being; partnering with our customers to find ways to make better use of the earth’s precious resources; and giving back to the communities where we live and work. Our equipment and technologies continue to deliver quality performance while striving to minimize food waste, extend food product life, support customer sustainability objectives, and maximize efficiency in order to create shared value for our food and beverage customers. While the majority of our impact lies within the solutions offered to our customers, our commitment to environmental responsibility extends to our own operations. We strive for our own facilities to operate efficiently and safely, much like the solutions we provide to our customers. We recognize our responsibility to make a positive impact on our stockholders, the environment and our communities in a manner that is consistent with our fiduciary duties. We have engaged in structured education for enhancing inclusive leadership skills in our organization designed to ensure a broad range of perspectives and backgrounds in our leadership and hiring practices.
Strategic Acquisition of Marel hf.
On January 2, 2025, the Company closed the acquisition of Marel hf., a multi-national food processing company based in Gardabaer, Iceland that manufactures equipment and provides other services primarily for food processing in the poultry, meat, and fish industries. The purpose of the Marel Transaction was to create a leading and diversified global food and beverage technology solutions provider by bringing together two renowned companies with long histories, complementary product portfolios, highly respected brands, and cutting-edge technology to enable global customers to more efficiently access industry leading technology worldwide. Refer to Note 2. Acquisitions of the Notes to the Consolidated Financial Statements for additional information on the Marel Transaction.
Business Conditions and Outlook
Our second quarter of 2025 financial performance exceeded our expectations, which was primarily driven by better than expected recurring revenue, foreign exchange translation, and operating leverage. Orders were healthy with strength across diverse end markets, including poultry, meat, fruit and vegetables, beverages, and ready meals.
Looking ahead, we anticipate that our second half of 2025 performance will be impacted by the evolving costs of tariffs. We continue to take proactive measures to mitigate tariff impacts on our products. These actions include reshoring third-party suppliers, vendor concessions, and further pricing considerations.
CONSOLIDATED RESULTS OF OPERATIONS
THREE MONTHS ENDED JUNE 30, 2025 AND 2024
(In millions, except %)
| Revenue | Three Months Ended June 30, 2025 | 2024 | Favorable/(Unfavorable) Change% | |
|---|---|---|---|---|
| JBT revenue | $454.6 | $402.3 | $52.3 | 13.0% |
| Marel revenue | 480.2 | — | 480.2 | n/a |
| Total revenue | 934.8 | 402.3 | 532.5 | 132.4% |
| Cost of sales | 600.6 | 259.1 | (341.5) | (131.8)% |
| Gross profit | 334.2 | 143.2 | 191.0 | 133.4% |
| Gross profit margin | 35.8% | 35.6% | 20 bps | |
| Selling, general and administrative expense | 250.4 | 110.4 | (140.0) | (126.8)% |
| Research and development | 30.9 | 5.8 | (25.1) | (432.8)% |
| Restructuring expense | 4.5 | 0.2 | (4.3) | (2,150.0)% |
| Operating income | 48.4 | 26.8 | 21.6 | 80.6% |
| Pension expense, other than service cost | 0.2 | 1.0 | 0.8 | 80.0% |
| Loss on investment | 10.6 | — | (10.6) | (100.0)% |
| Other (income) | (3.0) | — | (3.0) | 100.0% |
| Interest (income) | (2.8) | (5.7) | 2.9 | (50.9)% |
| Interest expense | 31.8 | 4.1 | (27.7) | (675.6)% |
| Income (loss) from continuing operations before income taxes | 11.6 | 27.4 | (15.8) | (57.7)% |
| Income tax provision (benefit) | 7.9 | (3.3) | (11.2) | (339.4)% |
| Equity in net loss of unconsolidated affiliate | 0.3 | — | (0.3) | (100.0)% |
| Income (loss) from continuing operations | $3.4 | $30.7 | $(27.3) | (88.9)% |
| Adjusted EBITDA from continuing operations (1) | $156.2 | $63.7 | $92.5 | 145.2% |
| Income (loss) from continuing operations margin | 0.4% | 7.6% | -720 bps | |
| Adjusted EBITDA margin from continuing operations (1) | 16.7% | 15.8% | 90 bps | |
| JBT segment Adjusted EBITDA | $81.7 | $63.7 | $18.0 | 28.3% |
| JBT segment Adjusted EBITDA margin | 18.0% | 15.8% | 220 bps | |
| Marel segment Adjusted EBITDA | $74.5 | $— | $74.5 | n/a |
| Marel segment Adjusted EBITDA margin | 15.5% | —% | n/a |
(1) Refer to the 'Reconciliation of Non-GAAP Measures' section below for additional information on Adjusted EBITDA from continuing operations.
Revenue
Total revenue for the three months ended June 30, 2025 increased $532.5 million or 132.4% compared to the same period in 2024. Organic revenue provided by the JBT segment increased $43.9 million and foreign currency translation was favorable by $8.4 million in the period compared to the prior year. The increase in organic revenue was primarily the result of an increase in volume for recurring revenue. The acquisition of Marel provided additional revenue of $480.2 million, which is inclusive of a favorable foreign currency translation impact of approximately $12.3 million.
Gross profit and Gross profit margin
Gross profit margin increased to 35.8% compared to 35.6% in the same period last year. This increase was primarily attributable to an increase in the JBT segment's gross profit margin from a higher volume of recurring revenue, partially offset by a lower gross profit margin of the acquired Marel business.
Selling, general and administrative expense
Selling, general and administrative expense increased $140.0 million compared to the same period in the prior year. This increase was primarily driven by the acquisition of Marel and higher costs associated with the integration. Selling, general and administrative expense as a percentage of revenue decreased by 60 bps to 26.8% compared to 27.4% in the same period last year. This decrease was primarily the result of better operating leverage from higher revenue as well as savings from our JBT Marel 2025 Integration restructuring plan.
Research and development
Research and development expense increased $25.1 million compared to the same period in the prior year. This increase is primarily the result of higher costs attributable to the recently acquired Marel business.
Loss on investment
The loss on investment of $10.6 million incurred during the three months ended June 30, 2025 relates to the Company's exit of an investment related to the acquisition of Marel.
Other income, interest income, and interest expense
Other income of $3.0 million during the three months ended June 30, 2025 relates to our cross-currency swap agreements that, for a portion of our Term Loan B debt, synthetically swap a higher interest expense based on the SOFR interest rate with a lower interest expense based on the EURIBOR interest rate and a credit spread.
Interest income decreased $2.9 million compared to the same period in 2024. This decrease was due to the Company having lower cash balances on hand to invest after funding the Marel Transaction in the first quarter of 2025.
Interest expense increased $27.7 million compared to same period last year. The increase was driven by a higher average debt balance as well as higher interest rates on additional borrowings to fund the Marel Transaction in the first quarter of 2025, compared to same period in 2024. Additional borrowing was drawn from our revolving credit facility and Term Loan B that was executed on January 2, 2025.
Income tax provision (benefit)
The Company's tax rate on the income from continuing operations was 68.1% for the three months ended June 30, 2025. The tax rate was high due to the combination of low pre-tax income, the impact of discrete items totaling $2.6 million, primarily driven by a non-deductible loss on investment, and changes to the full year forecasted tax rate.
The Company's tax rate on the income from continuing operations was (12.0)% for the three months ended June 30, 2024. The tax rate for the three months ended June 30, 2024 was favorably impacted by discrete items totaling $9.2 million, primarily driven by a non-recurring tax benefit related to an internal reorganization.
Income (loss) from continuing operations and Adjusted EBITDA
Income from continuing operations for the three months ended June 30, 2025 was $3.4 million compared to $30.7 million for the same period in 2024, representing a decrease of $27.3 million. The decrease was primarily due to higher interest expense, loss on investment, and the impact of discrete items on our income tax provision. This was partially offset by the operating income from the acquired Marel business, higher gross profit for the JBT segment, and savings from our JBT Marel 2025 Integration restructuring plan.
Adjusted EBITDA was $156.2 million for the three months ended June 30, 2025 compared to $63.7 million during the same period in 2024, representing an increase of $92.5 million. The increase in Adjusted EBITDA was primarily driven by incremental gross profit attributable to the recently acquired Marel business, partially offset by higher selling, general and administrative expense, excluding the impacts of our depreciation, amortization, and acquisition and integration costs.
Income from continuing operations margin decreased 720 bps to 0.4% compared to 7.6% for the same period in 2024. This decrease is the result of higher integration costs, higher interest expense, loss on investment, and the impact of discrete items on our income tax provision compared to the same period in 2024. However, Adjusted EBITDA margin increased 90 bps to 16.7% compared to 15.8% for the same period in 2024, primarily attributable to an increase in savings from our JBT Marel 2025 Integration restructuring plan as well as due to better operating leverage from higher revenue. This was partially offset by a lower gross profit margin for the acquired Marel business relative to the JBT business.
- JBT segment Adjusted EBITDA and Adjusted EBITDA margin was $81.7 million or 18.0% for the three months ended June 30, 2025 compared to $63.7 million or 15.8% for the same period in 2024. The increase of $18.0 million or 28.3% was primarily driven by an increase in gross profit from a favorable mix of higher recurring revenue compared to prior year, which tends to have higher margin than non-recurring revenue.
- Marel segment Adjusted EBITDA was $74.5 million and segment Adjusted EBITDA margin was 15.5% for the three months ended June 30, 2025.
CONSOLIDATED RESULTS OF OPERATIONS
SIX MONTHS ENDED JUNE 30, 2025 AND 2024
(In millions, except %)
| Revenue | Six Months Ended June 30, 2025 | 2024 | Favorable / (Unfavorable) Change% | |
|---|---|---|---|---|
| JBT revenue | $863.4 | $794.6 | $68.8 | 8.7% |
| Marel revenue | 925.5 | — | 925.5 | n/a |
| Total revenue | 1,788.9 | 794.6 | 994.3 | 125.1% |
| Cost of sales | 1,162.2 | 511.1 | (651.1) | (127.4)% |
| Gross profit | 626.7 | 283.5 | 343.2 | 121.1% |
| Gross profit margin | 35.0% | 35.7% | -70 bps | |
| Selling, general and administrative expense | 532.1 | 214.1 | (318.0) | (148.5)% |
| Research and development | 64.5 | 12.2 | (52.3) | (428.7)% |
| Restructuring expense | 15.1 | 1.3 | (13.8) | (1,061.5)% |
| Operating income | 15.0 | 55.9 | (40.9) | (73.2)% |
| Pension expense, other than service cost | 147.0 | 2.0 | (145.0) | (7,250.0)% |
| Loss on investment | 10.6 | — | (10.6) | (100.0)% |
| Other (income) | (5.0) | — | (5.0) | 100.0% |
| Interest (income) | (4.2) | (11.4) | 7.2 | (63.2)% |
| Interest expense | 74.2 | 7.0 | (67.2) | (960.0)% |
| Income (loss) from continuing operations before income taxes | (207.6) | 58.3 | (265.9) | (456.1)% |
| Income tax provision (benefit) | (38.3) | 4.8 | 43.1 | 897.9% |
| Equity in net loss of unconsolidated affiliate | 0.3 | 0.1 | (0.2) | (200.0)% |
| Income (loss) from continuing operations | (169.6) | 53.4 | (223.0) | (417.6)% |
| Income from discontinued operations, net of taxes | — | 0.1 | (0.1) | 100.0% |
| Net income (loss) | $(169.6) | $53.5 | $(223.1) | (417.0)% |
| Adjusted EBITDA from continuing operations (1) | $268.4 | $121.1 | $147.3 | 121.6% |
| Income (loss) from continuing operations margin | (9.5)% | 6.7% | -1620 bps | |
| Adjusted EBITDA margin from continuing operations | 15.0% | 15.2% | -20 bps | |
| JBT segment Adjusted EBITDA | $142.4 | $121.1 | $21.3 | 17.6% |
| JBT segment Adjusted EBITDA margin | 16.5% | 15.2% | 130 bps | |
| Marel segment Adjusted EBITDA | $126.0 | $— | $126.0 | n/a |
| Marel segment Adjusted EBITDA margin | 13.6% | —% | n/a |
(1) Refer to the 'Reconciliation of Non-GAAP Measures' section below for additional information on Adjusted EBITDA from continuing operations.
Revenue
Total revenue for the six months ended June 30, 2025 increased $994.3 million or 125.1% compared to the same period in 2024. Organic revenue provided by the JBT segment increased $66.9 million and foreign currency translation was favorable by $1.9 million in the period compared to the prior year. The increase in organic revenue was primarily the result of an increase in volume for recurring revenue. The acquisition of Marel provided additional revenue of $925.5 million, which is inclusive of a favorable foreign currency translation impact of approximately $1.8 million.
Gross Profit and Gross Profit Margin
Gross profit margin decreased 70 bps to 35.0% compared to 35.7% in 2024. The decrease was primarily attributable to a lower gross profit margin of the acquired Marel business, partially offset by an increase in the JBT segment's gross profit margin from higher volume for recurring revenue.
Selling, general and administrative expense
Selling, general and administrative expense increased $318.0 million compared to the same period in the prior year. Selling, general and administrative expense as a percentage of revenue increased 280 bps to 29.7% compared to 26.9% in the same period last year. This increase is primarily driven by higher costs attributable to the recently acquired Marel business and year over year increase of $74.7 million in M&A related costs attributable to the acquisition of Marel. This was partially offset by a better operating leverage from higher revenue as well as savings from our JBT Marel 2025 Integration restructuring plan.
Research and development
Research and development expense increased $52.3 million compared to the same period in the prior year. This increase is primarily the result of higher costs attributable to the recently acquired Marel business.
Pension expense, other than service cost
Pension expense, other than service cost increased $145.0 million compared to the same period in the prior year. This increase was primarily due to the settlement charge of $146.9 million recognized in the first quarter of 2025 upon the termination of the U.S. qualified defined benefit pension plan.
Loss on investment
The loss on investment of $10.6 million incurred during the six months ended June 30, 2025 relates to the Company's exit of an investment related to the acquisition of Marel.
Other income, interest income, and interest expense
Other income of $5.0 million during the six months ended June 30, 2025 relates to our cross-currency swap agreements that, for a portion of our Term Loan B debt, synthetically swap a higher interest expense based on the SOFR interest rate with a lower interest expense based on the EURIBOR interest rate and a credit spread.
Interest income decreased $7.2 million compared to the same period in 2024. This decrease was due to the Company having lower cash balances on hand to invest after funding the Marel Transaction in the first quarter of 2025.
Interest expense increased $67.2 million compared to same period last year. The increase was driven by a higher average debt balance as well as higher interest rates on additional borrowings to fund the Marel Transaction in the first quarter of 2025, compared to same period in 2024. Additional borrowing was drawn from our revolving credit facility and Term Loan B that was executed on January 2, 2025.
Income tax provision (benefit)
The Company's tax rate on the loss from continuing operations was 18.4% for the six months ended June 30, 2025. The tax benefit for the six months ended June 30, 2025 was reduced by discrete items totaling $5.0 million, primarily driven by non-deductible acquisition costs and a non-deductible loss on investment.
The Company's tax rate on the income from continuing operations was 8.2% for the six months ended June 30, 2024. The tax rate for the six months ended June 30, 2024 was favorably impacted by discrete items totaling $8.2 million, primarily driven by a non-recurring deferred tax benefit related to an internal reorganization.
Income (loss) from continuing operations and Adjusted EBITDA
Loss from continuing operations for the six months ended June 30, 2025 was $169.6 million compared to income from continuing operations of $53.4 million for the same period in 2024, representing a decrease of $223.0 million. The decrease was primarily due to higher pension expense other than service cost, interest expense, loss on investment, and the impact of discrete items on our income tax provision. This was partially offset by the operating income from the acquired Marel business, higher gross profit for the JBT segment, and savings from our JBT Marel 2025 Integration restructuring plan.
Adjusted EBITDA was $268.4 million for the six months ended June 30, 2025 compared to $121.1 million during the same period in 2024, representing an increase of $147.3 million. The increase in Adjusted EBITDA was primarily driven by incremental gross profit attributable to the recently acquired Marel business, partially offset by higher selling, general and administrative expense, excluding the impacts of our depreciation, amortization, and acquisition and integration costs.
Loss from continuing operations margin decreased 1620 bps to (9.5)% compared to 6.7% for the same period in 2024. This decrease is the result of higher pension expense other than service cost, higher integration costs, higher interest expense, the loss on investment, and the impact of discrete items on our income tax provision compared to the same period in 2024. However, Adjusted EBITDA margin decreased 20 bps to 15.0% compared to 15.2% for the same period in 2024. This decrease was primarily attributable to a lower gross profit margin and a higher selling, general, and administrative expense as a percentage of revenue for the acquired Marel business relative to the JBT business. This was partially offset by an year over year increase in the JBT segment's gross profit margin as well as savings from our JBT Marel 2025 Integration restructuring plan.
- JBT segment Adjusted EBITDA and Adjusted EBITDA margin was $142.4 million or 16.5% for the six months ended June 30, 2025 compared to $121.1 million or 15.2% for the same period in 2024. The increase of $21.3 million or 130 bps was primarily driven by an increase in gross profit from a favorable mix of higher recurring revenue compared to prior year, which tends to have higher margin than non-recurring revenue as well as savings from our JBT Marel 2025 Integration restructuring plan.
- Marel segment Adjusted EBITDA was $126.0 million and segment Adjusted EBITDA margin was 13.6% for the six months ended June 30, 2025.
Reconciliation of Non-GAAP Measures
We present non-GAAP financial measures in this quarterly report on Form 10-Q. These non-GAAP financial measures adjust for certain amounts that are otherwise included or excluded from a measure calculated under U.S. GAAP. By adjusting for these items, we believe we provide greater transparency into our operating results and trends, and a more meaningful comparison of our ongoing operating results, consistent with how management evaluates performance. Management uses these non-GAAP financial measures in financial and operational evaluation, planning and forecasting. We also believe that these non-GAAP measures are useful to investors as a way to evaluate and compare our operating performance against peers in the Company's industry. The adjustments generally fall within the following categories: restructuring costs, M&A related costs, pension-related costs, constant currency adjustments and other major items affecting comparability of our ongoing operating results.
The non-GAAP financial measures presented in this report may differ from similarly-titled measures used by other companies. The non-GAAP financial measures are not intended to be used as a substitute for, nor should they be considered in isolation of, financial measures prepared in accordance with U.S. GAAP.
Additional details for each Non-GAAP financial measure follow:
- Adjusted EBITDA and Adjusted EBITDA margin: We define Adjusted EBITDA as earnings adjusted for income taxes, interest expense (income), net, other financing income, pension expense other than service cost, restructuring, M&A related costs and depreciation and amortization, including acquisition related depreciation and amortization. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue.
- Adjusted income from continuing operations and Adjusted diluted earnings per share from continuing operations: We adjust earnings for restructuring expense, M&A related costs, which include integration costs, amortization of inventory step-up from business combinations, impacts of foreign currency derivatives and trades to hedge variability of exchange rates on the cash consideration paid for business combination, advisory and transaction costs for both potential and completed M&A transactions and strategy (“M&A related costs”), acquisition related amortization and depreciation, amortization of debt issuance costs related to bridge financing for potential M&A transactions, non-cash pension plan related settlement costs and the related tax impact.
- Free cash flow: We define free cash flow as cash provided by continuing operating activities, less capital expenditures, plus proceeds from sale of fixed assets and pension contributions. For free cash flow purposes, we consider contributions to pension plans to be more comparable to the payment of debt, and therefore exclude these contributions from the calculation of free cash flow.
- Constant currency measures: We evaluate our results of operations on both an as reported and a constant currency basis as it provides greater transparency into our operating results and trends, and a more meaningful comparison of our ongoing operating results. The constant currency presentation excludes the impact of fluctuations in foreign currency exchange rates. We calculate constant currency percentages by converting our financial results in local currency for a period using the average exchange rate for the prior period to which we are comparing.
The tables below reconcile each non-GAAP financial measure to the most comparable GAAP financial measure.
The following table presents a reconciliation of the Company's reported (Loss) income from continuing operations to Adjusted EBITDA from continuing operations.
(In millions)
| Three Months Ended June 30, 2025 | 2024 | Six Months Ended June 30, 2025 | 2024 | |
|---|---|---|---|---|
| Income (loss) from continuing operations | $3.4 | $30.7 | $(169.6) | $53.4 |
| Income tax provision (benefit) | 7.9 | (3.3) | (38.3) | 4.8 |
| Interest expense (income), net | 29.0 | (1.6) | 70.0 | (4.4) |
| Other financing (income) (1) | (3.0) | — | (5.0) | — |
| Loss on investment | 10.6 | — | 10.6 | — |
| Pension expense, other than service cost (2) | 0.2 | 1.0 | 147.0 | 2.0 |
| Restructuring related costs (3) | 5.6 | 0.2 | 16.2 | 1.3 |
| M&A related costs (4) | 20.0 | 14.5 | 94.4 | 19.7 |
| Depreciation and amortization (5) | 82.5 | 22.2 | 143.1 | 44.3 |
| Adjusted EBITDA from continuing operations | $156.2 | $63.7 | $268.4 | $121.1 |
(1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt.
(2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges.
(3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business.
(4) M&A related costs for the three and six months ended June 30, 2025, respectively, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $4.6 million and $57.7 million, amortization of inventory step-up from business combinations of $9.3 million and $19.9 million, and integration costs of $6.1 million and $16.8 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business.
(5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine Adjusted EBITDA.
The table below provides a reconciliation of income from continuing operations as reported to adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations.
(In millions, except per share data)
| Three Months Ended June 30, 2025 | 2024 | Six Months Ended June 30, 2025 | 2024 | |
|---|---|---|---|---|
| Income (loss) from continuing operations | $3.4 | $30.7 | $(169.6) | $53.4 |
| Non-GAAP adjustments | ||||
| Restructuring related costs | 5.6 | 0.2 | 16.2 | 1.3 |
| M&A related cost | 20.0 | 14.5 | 94.4 | 19.7 |
| Loss on investment | 10.6 | — | 10.6 | — |
| Amortization of bridge financing debt issuance cost | — | 1.2 | 12.4 | 1.2 |
| Acquisition related amortization and depreciation | 58.3 | 11.1 | 99.9 | 22.2 |
| Impact on tax provision from Non-GAAP adjustments(1) | (20.2) | (6.8) | (51.3) | (11.1) |
| Recognition of non-cash pension plan related settlement costs | — | — | 146.9 | — |
| Impact on tax provision from non-cash pension plan related settlement costs | — | — | (37.1) | — |
| Deferred tax benefit related to an internal reorganization | — | (8.8) | — | (8.8) |
| Discrete tax adjustment from M&A activity | — | — | 5.4 | — |
| Adjusted income from continuing operations | $77.7 | $42.1 | $127.8 | $77.9 |
| Income (loss) from continuing operations | $3.4 | $30.7 | $(169.6) | $53.4 |
| Total shares and dilutive securities | 52.2 | 32.2 | 51.9 | 32.2 |
| Diluted earnings per share from continuing operations | $0.07 | $0.95 | $(3.27) | $1.66 |
| Adjusted income from continuing operations | $77.7 | $42.1 | $127.8 | $77.9 |
| Total shares and dilutive securities | 52.2 | 32.2 | 52.0 | 32.2 |
| Adjusted diluted earnings per share from continuing operations | $1.49 | $1.31 | $2.46 | $2.42 |
(1) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for the quarters ended June 30, 2025 and 2024, respectively.
The table below provides a reconciliation of cash provided by operating activities to free cash flow:
(in millions)
| Six Months Ended June 30, 2025 | 2024 | |
|---|---|---|
| Cash provided by continuing operating activities | $136.6 | $32.0 |
| Less: capital expenditures | 38.5 | 21.0 |
| Plus: proceeds from sale of fixed assets | 4.5 | 0.9 |
| Plus: pension contributions | 3.2 | 1.6 |
| Free cash flow (FCF) | $105.8 | $13.5 |
Free cash flow during the six months ended June 30, 2025 was $105.8 million, which includes payment for acquisition costs of the Marel Transaction of approximately $100 million, representing a $92.3 million increase compared to the same period in 2024.
Restructuring
In the third quarter of 2022, the Company implemented a restructuring plan (the "2022/2023 restructuring plan") to optimize the overall cost structure for the Company on a global basis. The initiatives under this plan included streamlining operations and enhancing our general and administrative infrastructure. The 2022/2023 restructuring plan was completed as of March 31, 2024. The total cost in connection with this plan was $17.5 million.
In the first quarter of 2025, the Company implemented the JBT Marel 2025 Integration restructuring plan to achieve a portion of its synergy targets identified as a result of the Marel acquisition to optimize the overall cost structure for the combined Company on a global basis. The initiatives under this plan included streamlining operations and adjusting our general and administrative infrastructure to meet the strategic needs of JBT Marel. The total estimated cost in connection with this plan is in the range of approximately $25.0 million to $30.0 million. The Company recognized restructuring charges of $16.7 million, net of a cumulative release of the related liability of $0.1 million through June 30, 2025, and expects to recognize the remaining costs by the end of 2026.
The following table details the cumulative amount of annualized savings and incremental savings for the JBT Marel 2025 Integration restructuring plan:
(In millions)
| Cumulative Amount As of December 31, 2024 | Incremental Amount During the quarter ended March 31, 2025 | During the quarter ended June 30, 2025 | Cumulative Amount As of June 30, 2025 | |
|---|---|---|---|---|
| Cost of sales | $— | $— | $0.8 | $0.8 |
| Selling, general and administrative | — | 2.0 | 4.3 | 6.3 |
| Total restructuring savings | $— | $2.0 | $5.1 | $7.1 |
Cumulative cost savings for the JBT Marel 2025 Integration restructuring plan are expected to be between $50.0 million and $60.0 million. Savings expected to be realized during the remainder of 2025 are approximately $15.0 million.
For additional financial information about restructuring, refer to Note 15. Restructuring of the Notes to the Condensed Consolidated Financial Statements.
Liquidity and Capital Resources
Overview of Sources and Uses of Cash
Our primary sources of liquidity are cash flows provided by operating activities from our U.S. and foreign operations, our revolving credit facility, and our cash and cash equivalents on hand. In connection with the Marel Transaction, we drew an additional $604 million from our existing revolving credit facility on December 30, 2024. On January 2, 2025, we secured takeout financing comprised of the amended and restated 5-year, $1.8 billion revolving credit facility and $900 million in the Senior Secured Term Loan B ("Term Loan B"). The takeout financing resulted in the carryforward of the initial $604 million borrowing from our existing revolving credit facility and additional borrowings of $900 million drawn from the Term Loan B and $18.6 million from the amended revolving credit facility to fund the Marel Transaction, subsequent acquisition of the non-controlling interest of Marel, and related expenditures.
On January 2, 2025, we closed the Marel Transaction by acquiring approximately 97.5% of Marel's issued and outstanding equity interests. On February 4, 2025, we acquired the remaining 2.5% of Marel's issued and outstanding equity interests ("Squeeze out"). Upon the closing of the Marel Transaction on January 2, 2025 and the Squeeze out on February 4, 2025, we used available cash and additional borrowings from the takeout financing to fund $983.7 million of cash consideration paid to the Marel shareholders, $867.8 million for repayment of Marel's debt, $111.4 million for transaction related expenses, and $16.1 million for debt issuance costs.
For the six months ended June 30, 2025, we had total operating cash flows from continuing operations of $136.6 million. For full year 2025, we expect to generate positive cash flows. Our liquidity as of June 30, 2025, or cash plus borrowing ability under our existing revolving credit facilities, was $1.3 billion. The takeout financing includes a leverage holiday that permits a maximum secured leverage ratio of 5.0x for the initial 12-months after the Marel Transaction close date and a total leverage ratio of 5.75x.
Our liquidity is available for repayment of the Notes and to support the integration of JBT and Marel and our other capital allocation priorities. Based on our current capital allocation objectives, we anticipate capital expenditures to be between $85 million and $95 million during 2025. Our level of capital expenditures varies from time to time as a result of actual and anticipated business conditions. During 2025, we also expect to incur integration costs and other synergy-related costs in the range of $45 million to $55 million related to the acquisition of Marel.
Additionally, the cash flows generated by our continuing operations are expected to be sufficient to satisfy our principal cash requirements that include our working capital needs, new product development, restructuring expenses, capital expenditures, income taxes, debt interest and repayments, dividends, and other financing arrangements.
As of June 30, 2025, we had $111.8 million of cash and cash equivalents, $24.9 million of which was held by our foreign subsidiaries. Although certain funds are considered permanently invested in our foreign subsidiaries, we are not presently aware of any restriction on the repatriation of these funds. We maintain significant operations outside of the U.S., and many of our uses of cash for working capital, capital expenditures and business acquisitions arise in these foreign jurisdictions. If these funds were needed to fund our operations or satisfy obligations in the U.S., they could be repatriated and their repatriation into the U.S. could cause us to incur additional U.S. income tax and foreign withholding taxes. The foreign withholding taxes on these repatriations to the U.S. would potentially be partially offset by U.S. foreign tax credits.
As noted above, certain funds held outside of the U.S. are considered permanently invested in our non-U.S. subsidiaries. At times, these foreign subsidiaries have cash balances that exceed their immediate working capital or other cash needs. In these circumstances, the foreign subsidiaries may loan funds to the U.S. parent company on a temporary basis; the U.S. parent company has in the past and may in the future use the proceeds of these temporary intercompany loans to reduce outstanding borrowings under our committed credit facilities. By using available non-U.S. cash to repay our debt on a short-term basis, we can optimize our leverage ratio, which has the effect of lowering our interest costs.
Cash Flows
Cash flows for the six months ended June 30, 2025 and 2024 were as follows:
(In millions)
| Six Months Ended June 30, 2025 | 2024 | |
|---|---|---|
| Cash provided by continuing operating activities | $136.6 | $32.0 |
| Cash required by continuing investing activities | (1,780.1) | (22.7) |
| Cash provided (required) by continuing financing activities | 543.4 | (16.4) |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1.7 | (1.8) |
| Net decrease in cash from continuing operations | $(1,098.4) | $(8.9) |
Cash provided by continuing operating activities during the six months ended June 30, 2025 was $136.6 million, representing a $104.6 million increase compared to the same period in 2024. This increase was driven primarily by higher collections of customer advanced payments and trade receivables and lower payments of accounts payable, partially offset by higher purchases of inventory during the period.
Cash required by investing activities was $1,780.1 million during the six months ended June 30, 2025, compared to cash required of $22.7 million during the same period in 2024. The cash outflow during the period was primarily due to the acquisition of Marel.
Cash provided by financing activities was $543.4 million during the six months ended June 30, 2025, compared to cash required of $16.4 million during the same period in 2024. The cash inflows during the period were the result of the draw on the revolving credit facility and funding of the Term Loan B, partially offset by the payment of debt issuance costs related to the Second A&R Credit Agreement.
Financing Arrangements
As of June 30, 2025, we had $638.2 million drawn on and $1.2 billion of availability under the revolving credit facility.
Our Second A&R Credit Agreement includes restrictive covenants that, if not met, could lead to a renegotiation of our credit lines, a requirement to repay our borrowings and/or a significant increase in our cost of financing. Restrictive covenants include a minimum interest coverage ratio, a maximum leverage ratio, as well as certain events of default. As of June 30, 2025, we were in compliance with all covenants in the Second A&R Credit Agreement. We expect to remain in compliance with all covenants.
On January 2, 2025, we executed takeout financing consisting of an amended and restated 5-year, $1.8 billion revolving credit facility and a 7-year, $900 million senior secured term loan B. The amended revolving credit facility retained the same pricing grid as our previous revolving credit facility. The Term Loan B provides for secured pricing of SOFR plus 225 basis points. This pricing structure will step down to SOFR plus 200 basis points once leverage, as defined in the Second A&R Credit Agreement, is below 3.25x. During the second quarter of 2025, we achieved leverage below 3.25x and the pricing structure of SOFR plus 200 basis points will go into effect during the third quarter of 2025.
On May 28, 2021, we closed a private offering of $402.5 million aggregate principal amount of the Company's 0.25% Convertible Senior Notes due 2026 to qualified institutional buyers, resulting in net proceeds to us of approximately $392.2 million after deducting initial purchasers’ discounts. The Notes will mature on May 15, 2026 unless earlier converted, redeemed or repurchased. Concurrently with the issuance of the Notes, we entered into the convertible note hedge transactions that reduce potential dilution upon conversion of the Notes and entered into the warrant transactions to raise additional capital to partially offset the costs of entering into the convertible note hedge transactions.
For additional information about our Notes, convertible note hedge transactions and warrant transactions, refer to Note 6. Debt of the Notes to the Condensed Consolidated Financial Statements.
As of June 30, 2025, a portion of our total gross outstanding debt of $1,939.2 million effectively remained fixed rate debt, with the Notes subject to a fixed rate of 0.25%. Our revolving credit facility and Term Loan B are subject to floating, or market rates, in addition to a premium charged for their respective credit spreads. Approximately $1,536.0 million or 79% of the total debt balance as of June 30, 2025 was variable rate debt and subject to floating rates.
On January 3, 2025, we entered into five cross-currency swaps expiring in January 2032 related to the portion of the U.S. dollar denominated Term Loan B debt drawn down by JBT Marel's European entity. These cross currency swap agreements have a combined notional amount of $698.3 million and synthetically swapped an average SOFR interest rate of 4.32% with an average EURIBOR rate of 2.44% for the six months ended June 30, 2025, to hedge the impact of variability in exchange rates on the U.S. dollar dominated debt and related interest payments, excluding credit spread, by our euro-functional entity.
CRITICAL ACCOUNTING ESTIMATES
Other than discussed below, there have been no material changes in our judgments and assumptions associated with the development of our critical accounting estimates during the period ended June 30, 2025. Refer to our Annual Report on Form 10-K for the year ended December 31, 2024 for a discussion of our critical accounting estimates.
Intangible Asset Valuation
Accounting for business combinations requires management to make significant estimates and assumptions at the acquisition date specifically for the valuation of intangible assets. We use the multi-period excess earnings method, a type of income approach, to determine the fair value of the customer relationships and the relief-from-royalty method, a type of income approach, to determine the fair value of the trademarks and acquired technology. Critical estimates and assumptions in valuing certain of the intangible assets we have acquired include, but are not limited to, forecasted revenue growth rates, EBITDA margins, discount rates, customer attrition rates and royalty rates. The discount rates used to discount expected future cash flows to present value are typically derived from a weighted-average cost of capital analysis and adjusted to reflect inherent risks. The customer attrition rate was selected based on historical experience and information obtained from Marel management. The royalty rates used in the valuation of the trademarks and acquired technology intangible assets were based on a detailed analysis considering the importance of the trademarks and technology to the overall enterprise and market royalty data.
Unanticipated events and circumstances may occur that could affect either the accuracy or validity of such assumptions, estimates or actual results. While we use our best estimates and assumptions, fair value estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill.
Future changes in the estimates and assumptions that are used in our acquisition valuations and intangible asset and goodwill impairment testing, including discount rates or future operating results and related cash flow projections, could result in significantly different estimates of the fair values in the future. An increase in discount rates, a reduction in projected cash flows or a combination of the two could lead to a reduction in the estimated fair values, which may result in impairment charges that could materially affect our financial statements in any given year.
Market risk
As filed, 1,857 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Other than as discussed below, there have been no material changes with respect to our exposure to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2024.
Foreign Currency Exchange Rate Risk
In January 2025, we entered into five cross-currency swaps related to the portion of the U.S. dollar denominated Term Loan B drawn down by JBT Marel's European entity. These cross currency swap agreements have a combined notional amount of $698.3 million and synthetically swap interest rates from SOFR to EURIBOR and hedge the impact of variability in exchange rates on the U.S. dollar dominated debt and related interest payments, excluding credit spread, by our euro-functional entity. The aggregate fair value of these swaps was a liability position of $119.4 million at June 30, 2025. We use a sensitivity analysis to measure the impact of an immediate 10% adverse movement in the foreign currency exchange rates underlying these swaps. A hypothetical 10% adverse movement in the currency exchange rates underlying these swaps from the market rate at June 30, 2025 would have resulted in a loss in value of the swaps by $66.2 million.
In June 2025, the Company entered into a series of cross currency swaps with an aggregate notional amount of $578 million (€500 million) to hedge the currency exchange component of our net investments in certain of our foreign subsidiaries. The aggregate fair value of these swaps was in a liability position of $12.4 million at June 30, 2025. We use a sensitivity analysis to measure the impact of an immediate 10% movement in the foreign currency exchange rates underlying these swaps. A hypothetical adverse movement in the currency exchange rates underlying these swaps from the market rate at June 30, 2025 would have resulted in a loss in value on the swaps by $58.6 million.
Controls and procedures
As filed, 5,391 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Under the direction of our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 30, 2025. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2025, our disclosure controls and procedures were effective.
The Company completed the acquisition of Marel hf. (“Marel”) on January 2, 2025 in a purchase business combination. As discussed in Securities and Exchange Commission (“SEC”) staff guidance, a company may conclude it will exclude an acquired business from the assessment of internal control over financial reporting during the first year after completion of an acquisition. In light of the overlap between a company’s disclosure controls and procedures and its internal control over financial reporting, the evaluation of disclosure controls and procedures may also exclude an assessment of the disclosure controls and procedures of the acquired entity that are subsumed in internal control over financial reporting. In consideration of the SEC staff guidance, we excluded Marel from our assessment of the effectiveness of disclosure controls and procedures as of June 30, 2025. Marel’s total assets and total revenues excluded from our assessment represented approximately 17% and 52% of the Company’s consolidated total assets and consolidated total revenues, respectively, as of and for the six months ended June 30, 2025.
Material Weaknesses Related to Marel hf.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
Prior to the acquisition, Marel management identified the following material weaknesses in its internal control over financial reporting, which remained unremediated as of June 30, 2025:
- Information Technology: The Company’s acquired entity, Marel, did not design and maintain effective information technology general controls for information systems that are relevant to financial reporting. Specifically, Marel did not design and maintain: (i) program change management controls to ensure that information technology program and data changes are identified, tested, authorized, and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and to adequately restrict user and privileged access to appropriate personnel; (iii) computer operations controls to ensure that processing and transfer of data, and data backups and recovery are monitored; and (iv) program development controls to ensure that new software development is tested, authorized and implemented appropriately.
These IT deficiencies did not result in a material misstatement to the financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected.
- Journal entries: The Company’s acquired entity, Marel, did not design or maintain effective controls over the recording and review of journal entries for validity, accuracy, and completeness. Specifically, certain key accounting personnel had the ability to prepare and post journal entries without an appropriately designed independent review. This material weakness did not result in a material misstatement to the financial statements.
While the above material weaknesses have not resulted in a material misstatement to the financial statements, such material weaknesses have resulted in misstatements that are not material to our financial statements as of and for the three months ended March 31, 2025. The above material weaknesses could result in additional misstatements of Marel’s accounts or disclosures, which could result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
The Company is in the process of completing remediation activities including designing and implementing controls to address the identified material weaknesses, and is working to implement its internal control structure over the acquired operations. The Company continues the process of reviewing the operations of Marel and may identify additional material weaknesses.
Changes in Internal Control Over Financial Reporting
During the quarter ended June 30, 2025, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended June 30, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 5,703 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information set forth in this report, you should carefully consider the risk factor below and factors discussed in Item 1A. "Risk Factors" in JBT Marel's Annual Report on Form 10-K for the year ended December 31, 2024 and Item 1A. "Risk Factors" in JBT Marel's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
Material weaknesses were identified in Marel's internal control over financial reporting and we may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting, which could result in material misstatements of Marel's accounts and disclosures.
Prior to the acquisition, Marel was not subject to the information and reporting requirements of the Exchange Act, the Sarbanes-Oxley Act or other U.S. federal securities laws, including the compliance obligations relating to, among other things, the maintenance of a system of internal controls as contemplated by the Exchange Act and the Sarbanes-Oxley Act. We need to timely and effectively design and implement controls and procedures over Marel’s operations necessary to satisfy those requirements. We intend to take appropriate measures to design and implement internal controls at Marel aimed at successfully fulfilling these requirements on the timeline allowed by the rules of the Securities and Exchange Commission. However, it is possible that we may experience delays in implementing the appropriate internal controls and procedures relating to Marel's operations, which could result in increased costs, enforcement actions, the assessment of penalties and civil suits, failure to meet reporting obligations and other material and adverse events that could have a negative effect on our operations.
As discussed in Item 4. above, prior to the acquisition of Marel, its management identified two material weaknesses in its internal control over financial reporting, which remained unremediated as of June 30, 2025. Specifically, its management identified that 1) Marel did not design and maintain effective information technology general controls for information systems that are relevant to financial reporting. Specifically, Marel did not design and maintain: (i) program change management controls to ensure that information technology program and data changes are identified, tested, authorized, and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and to adequately restrict user and privileged access to appropriate personnel; (iii) computer operations controls to ensure that processing and transfer of data, and data backups and recovery are monitored; and (iv) program development controls to ensure that new software development is tested, authorized and implemented appropriately. These IT deficiencies did not result in a material misstatement to the financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected, and 2) Marel did not design or maintain effective controls over the recording and review of journal entries for validity, accuracy, and completeness. Specifically, certain key accounting personnel had the ability to prepare and post journal entries without an appropriately designed independent review. This material weakness did not result in a material misstatement to the financial statements; however, it could result in a potential misstatement of Marel's accounts or disclosures that could result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected. If we experience a delay in successfully remediating any identified control deficiencies, including current or future material weaknesses in our internal control over financial reporting, the accuracy and timing of our financial reporting may be adversely affected; our liquidity, access to capital markets and perceptions of our creditworthiness may be adversely affected; we could face difficulty forecasting our financial results accurately, impacting decision-making by investors and analysts; we may be unable to maintain compliance with securities laws, stock exchange listing requirements and debt instruments’ covenants regarding the timely filing of periodic reports; we may be subject to regulatory investigations and penalties; investors may lose confidence in our financial reporting; we may suffer defaults under our debt instruments; and our common stock price may decline.
Further, as discussed in Item 4. above, we have and may continue to discover weaknesses in Marel's system of internal control over financial reporting that could result in a material misstatement of Marel's accounts and disclosures. Our internal control over financial reporting may not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $934.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-01-01 to 2025-06-30 | $1.79bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-04-01 to 2025-06-30 | $600.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-01-01 to 2025-06-30 | $1.16bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2025-04-01 to 2025-06-30 | $30.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2025-01-01 to 2025-06-30 | $64.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-04-01 to 2025-06-30 | $250.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-01-01 to 2025-06-30 | $532.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-04-01 to 2025-06-30 | $48.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-01-01 to 2025-06-30 | $15.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-04-01 to 2025-06-30 | $31.8m | us-gaap:InterestExpense |
| Interest expense | 6 months2025-01-01 to 2025-06-30 | $74.2m | us-gaap:InterestExpense |
| Income tax | 3 months2025-04-01 to 2025-06-30 | $7.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-01-01 to 2025-06-30 | −$38.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-01 to 2025-06-30 | $3.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-01-01 to 2025-06-30 | −$169.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-01-01 to 2025-06-30 | −$3.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | $0.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-01-01 to 2025-06-30 | −$3.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 52,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-01-01 to 2025-06-30 | 51,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months2025-01-01 to 2025-06-30 | $38.5m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2025-01-01 to 2025-06-30 | $10.5m | us-gaap:PaymentsOfDividends |
| Current assets | At period end2025-06-30 | $1.53bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-30 | $8.25bn | us-gaap:Assets |
| Current liabilities | At period end2025-06-30 | $1.64bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2025-06-30 | $1.51bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2025-06-30 | $410.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-06-30 | $4.37bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001433660-25-000045. Last ingested by Listed: Nov 3, 2026, 21:30 ET. Listed shows no prices and gives no investment advice.